PENG Block for Traumatic Hip Fracture in the Emergency Department
A Comparison of Ultrasound-guided Pericapsular Nerve Group (PENG) Block and Parenteral Opioids Alone in Patients With Traumatic Hip Fracture in the Emergency Department: A Multicenter Randomized Controlled Trial
1 other identifier
interventional
65
1 country
1
Brief Summary
The study is a multicenter single-blinded randomized comparative trial. Adult patients older than 20 years of age presenting with acute hip fracture in emergency department between January 1st, 2021 and December 31st, 2021 will be enrolled. (NOTE: The study was paused temporarily due to local SARS-2 COVID-19 virus pandemic restrictions. Finally, we conducted the study from August 30th, 2021 to May 08th, 2022.) Included patients will receive analgesia with either pericapsular nerve group (PENG) block or intravenous morphine. The primary outcome measure was pain scores (Numeric Rating Scale (NRS) 0 to 10) at rest and with movement. Secondary outcomes were rescue opioids use, complications, length of hospital stay, and patient-reported outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2021
CompletedFirst Posted
Study publicly available on registry
August 10, 2021
CompletedStudy Start
First participant enrolled
August 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 8, 2022
CompletedJanuary 18, 2023
January 1, 2023
8 months
July 22, 2021
January 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity difference (PID)
Pain intensity was investigated at rest and with movement using the 11-point numeric rating-scale (NRS) from 0 (no pain) to 10 (worst pain), and pain-intensity difference(PID) represents the difference in NRS scores between any observation time and the baseline.
24 hours
Secondary Outcomes (5)
postdose quadriceps strength
24 hours
Rescue opioid consumption
24 hours
Incidence of nerve block complications
24 hours
Incidence of opioid side effects
24 hours
Patient-reported outcome
24 hours
Study Arms (2)
Ultrasound-guided Pericapsular Nerve Group (PENG) Block
EXPERIMENTALPENG blocks is performed by Emergency Medicine board-certified emergency physicians (EPs) with standard training program. PENG block is performed using a spinal needle (NIPRO® 21G × 70 mm) at the level of of anterior superior iliac spine, parallel to the inguinal crease, with real-time ultrasound guidance, according to the steps published by Girón-Arango et al in 2018. The investigators use 20 ml of 1% lidocaine for nerve block because this drug has a short onset time, which is adequate to relieve pain before surgical intervention.
Intravenous Morphine
ACTIVE COMPARATORDosage of intravenous morphine was determined according to 0.1 mg per kg; EPs were instructed to aim to reduce the pain by 50% or per patient request.
Interventions
PENG blocks is performed by Emergency Medicine board-certified emergency physicians (EPs) with standard training program. PENG block is performed using a spinal needle (NIPRO® 21G × 70 mm) at the level of of anterior superior iliac spine, parallel to the inguinal crease, with real-time ultrasound guidance, according to the steps published by Girón-Arango et al in 2018. The investigators use 20 ml of 1% lidocaine for nerve block because this drug has a short onset time, which is adequate to relieve pain before surgical intervention.
Eligibility Criteria
You may qualify if:
- Patients aged \>20 years presenting to the ED with a diagnosis of traumatic hip fracture during the study timeframe.
You may not qualify if:
- are aged \<20 years
- coagulopathy
- injection site infection
- allergy to opioids or local anesthetics
- initial pulse oximetry measures of oxygen saturation \<92%
- initial systolic blood pressure \< 90 mmHg
- chronic opioid use
- non-communicative
- major trauma
- fractures happened \> 24 hours
- request conservative(non-operative) treatments.
- The investigators also exclude patients if the NB providers are unavailable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dalin Tzu Chi General Hospitallead
- Far Eastern Memorial Hospitalcollaborator
Study Sites (1)
Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Chiayi City, 622, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Emergency department physician, Principal Investigator
Study Record Dates
First Submitted
July 22, 2021
First Posted
August 10, 2021
Study Start
August 30, 2021
Primary Completion
May 8, 2022
Study Completion
May 8, 2022
Last Updated
January 18, 2023
Record last verified: 2023-01